Talent development in remote working MasterClass

This course will help HR professionals to connect to future business reality and take their place at the strategic level decision making concerning talent development. The aim is to give HR business partners a model for the practical implementation of the Learning and Development systems in a remote working environment and inspire strategic thinking in…

This course will help HR professionals to connect to future business reality and take their place at the strategic level decision making concerning talent development. The aim is to give HR
business partners a model for the practical implementation of the Learning and Development systems in a remote working environment and inspire strategic thinking in HRD for business
strategy implementation.

Talent development in remote working MasterClass

This course will help HR professionals to connect to future business reality and take their place at the strategic level decision making concerning talent development. The aim is to give HR business partners a model for the practical implementation of the Learning and Development systems in a remote working environment and inspire strategic thinking in…

This course will help HR professionals to connect to future business reality and take their place at the strategic level decision making concerning talent development. The aim is to give HR
business partners a model for the practical implementation of the Learning and Development systems in a remote working environment and inspire strategic thinking in HRD for business
strategy implementation.

European Internal Audit Summit 2021

European Internal Audit Summit 2021 is designed to uncover the insights of the most emerging topics. The attendees will be presented with a number of sessions on today’s current issues and trends, industry best practices seeking to address common challenges, and knowledge-sharing opportunities. The conference will be a great combination of experts from all over…

European Internal Audit Summit 2021 is designed to uncover the insights of the most emerging topics. The attendees will be presented with a number of sessions on today’s current issues and trends, industry best practices seeking to address common challenges, and knowledge-sharing opportunities. The conference will be a great combination of experts from all over the world to share their views through case studies, keynote presentations, and interactive panel discussions. It will equip participants with the appropriate strategies to perform proactively in order to stay on top of their business.

Listen to the top leading companies sharing their challenges and management strategies and then connect with the industry’s ndustry giants and exchange your experience.

Join our European Internal Audit Forum to unfold solutions to the challenges you have!

Choosing a CCP: Strategic, Credit and Operational MasterClass

Choosing a CCP: Strategic, Credit and Operational considerations is a two part module looking at the criteria involved in selecting a CCP to work with. The first part is the strategic discussion around the most important considerations involved (eg: one CCP to optimise netting benefits or multiple to diversify risk?) and ensuring it meets your…

Choosing a CCP: Strategic, Credit and Operational considerations is a two part module looking at the criteria involved in selecting a CCP to work with.
The first part is the strategic discussion around the most important considerations involved (eg: one CCP to optimise netting benefits or multiple to diversify risk?) and ensuring it meets your institution’s requirements, together with the broader debate around where CCPs sit in the Capital Markets Infrastructure and how things might play out if things go wrong (recovery and resolution regime, importance of CCP to the smooth running of the markets).
The second part is about Credit and Operational issues. How traditional cash flow forecasting measures are of limited benefit compared to understanding the rigour of a CCPs margining process, it’s payment waterfall, and the mutualisation of risk from its members.
Then we look at some of the collateral issues arising from dealing with CCPs, as well as some of the potential operational problems.
Finally, we look at some of the topics you might want to cover at a due diligence meeting with a CCP.

Choosing a CCP: Strategic, Credit and Operational MasterClass

Choosing a CCP: Strategic, Credit and Operational considerations is a two part module looking at the criteria involved in selecting a CCP to work with. The first part is the strategic discussion around the most important considerations involved (eg: one CCP to optimise netting benefits or multiple to diversify risk?) and ensuring it meets your…

Choosing a CCP: Strategic, Credit and Operational considerations is a two part module looking at the criteria involved in selecting a CCP to work with.
The first part is the strategic discussion around the most important considerations involved (eg: one CCP to optimise netting benefits or multiple to diversify risk?) and ensuring it meets your institution’s requirements, together with the broader debate around where CCPs sit in the Capital Markets Infrastructure and how things might play out if things go wrong (recovery and resolution regime, importance of CCP to the smooth running of the markets).
The second part is about Credit and Operational issues. How traditional cash flow forecasting measures are of limited benefit compared to understanding the rigour of a CCPs margining process, it’s payment waterfall, and the mutualisation of risk from its members.
Then we look at some of the collateral issues arising from dealing with CCPs, as well as some of the potential operational problems.
Finally, we look at some of the topics you might want to cover at a due diligence meeting with a CCP.

Pharma Real-World Evidence MasterClass

Today we can no longer afford to undertake randomized effectiveness trials that cost tens or hundreds of millions of dollars. But today we also have registries and other powerful digital platforms. Today it may be possible to design and conduct megatrials with what we have: bigger data and smaller budgets. Real-World Data (RWD) has become…

Today we can no longer afford to undertake randomized effectiveness trials that cost tens or hundreds of millions of dollars. But today we also have registries and other powerful digital platforms. Today it may be possible to design and conduct megatrials with what we have: bigger data and smaller budgets.

Real-World Data (RWD) has become a fundamental tool for the development and demonstration of the value of any new health technology, through the observation of what happens in real clinical practice. Real-World Evidence (RWE) is a key opportunity to better understand the disease, patient needs, and to improve healthcare processes. RWE promises that a rich diversity of data collected from extremely large patient samples will produce more precise, targeted, and therefore more effective healthcare at the individual patient level.

An integrated patient-centric perspective among different stakeholders and a focus on continuous evidence generation is the way forward for the life science industry. The methods for generating RWE are extremely heterogeneous as they include different study designs and types and various data sources. However, all RWE projects, with the sole exception of pragmatic trials, share the same scientific methodology as observational research. For this reason, methodological and scenario aspects of observational research will be addressed, as well as insights into specific types of projects and the impact of new technologies in this area. These basics information will be revised to envision how real-world evidence should be incorporated throughout the product’s lifecycle to ensure a significant value during its launch and commercialization.

The Social Responsibility of Pharmaceutical Companies in Times of Crisis MasterClass

The concept and practices of Corporate Social Responsibility have evolved in the last two decades at an increasing pace. Shaped by the public pressure and the exigencies of the industry, the CSR/ Sustainability programs became more and more focused on social engagement and consistency in corporate response. This four half-days training takes this and projects…

The concept and practices of Corporate Social Responsibility have evolved in the last two decades at an increasing pace. Shaped by the public pressure and the exigencies of the industry, the CSR/ Sustainability programs became more and more focused on social engagement and consistency in corporate response. This four half-days training takes this and projects it into various scenarios dominated by crises: from drug scarcity and medical or environmental crises to distribution failures and political conflicts. The main question is how can a Pharmaceutical company address its social responsibility in such a scenario and have its response validated by its stakeholders. All training activities will be online and include short presentations, case study analysis, group tasks using breakout rooms, jamboards, as well as project-based tasks. The trainees will receive the four case studies one week prior to the training and have the obligation to read it thoroughly before joining the first session. All training activities will be based on these four case studies.

IFRS 9 Expected Credit Loss Modelling MasterClass

The ECL MasterClass was designed to improve the level of knowledge in the field of modelling requirements from IFRS 9, the EBA Stresstest-Methodology, the EBA IRB-Guidelines, and the upcoming Basel IV standards. The MasterClass approach is vastly practical. It will help you to understand fundamental concepts and principles underlying the many new regulations and equip…

The ECL MasterClass was designed to improve the level of knowledge in the field of modelling requirements from IFRS 9, the EBA Stresstest-Methodology, the EBA IRB-Guidelines, and the upcoming Basel IV standards. The MasterClass approach is vastly practical. It will help you to understand fundamental concepts and principles underlying the many new regulations and equip participants with the knowledge to handle the practical implementation challenges and to sort out the complex differences.

The ECL MasterClass is essential for professionals in the field of accounting, auditing, and finance, who are aiming for career development. The MasterClass will cover new regulatory topics and the main implications of COVID19 on ECL modelling.

VBA & Innovative Contracting in Pharma MasterClass

As healthcare shifts from “volume to value” we are seeing a global trend of shifting medicines and technology pricing towards a value based paradigm. This comprehensive symposium will cover off “value based agreements” and innovative financial contracts between pharmaceutical manufactures and payers. We will go through VBA nomenclature through to design and architecture of value…

As healthcare shifts from “volume to value” we are seeing a global trend of shifting medicines and technology pricing towards a value based paradigm. This comprehensive symposium will cover off “value based agreements” and innovative financial contracts between pharmaceutical manufactures and payers. We will go through VBA nomenclature through to design and architecture of value based agreements across different drug types, therapy areas and payer archetypes. There will be case presentations of successful VBA from across the globe, focusing on US & EU markets, with market analysis and deconstruction of these agreements. There will be a focus on “why do a VBA” and key drivers from manufacturers and payers to ensure success for all parties for access and reimbursement with innovative contracting mechanisms. Finally, we will explore how pharmaceutical manufacturers are undertaking organizational change as they move up the VBA adoption curve and improve resource and x-functional team working. To support successful deployment and scalability of VBA’s across in market and pipeline portfolio products.

Evolution of the Executive Assistant MasterClass

Global lockdown has caught most companies and most Assistants highly unprepared for remote work. How can Assistants make their role indispensable and their careers bulletproof? Which technology is the best for virtual offices and remote work? How to choose your next learning step with so much material suddenly available online? And finally – how can…

Global lockdown has caught most companies and most Assistants highly unprepared for remote work.
How can Assistants make their role indispensable and their careers bulletproof?
Which technology is the best for virtual offices and remote work?
How to choose your next learning step with so much material suddenly available online? And finally – how can Assistants pioneer change and become strategic partners in their companies?